FANTA KAMARA: Open Payments
NPI 1972990612 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $87 |
| Amgen Inc. | 4 | $78 |
| Mallinckrodt Hospital Products Inc. | 2 | $70 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| Novo Nordisk Inc | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| ABIOMED | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: TARPEYO, Kerendia, TAVNEOS, ACTHAR, PREVYMIS, Vanrafia, Ozempic, FARXIGA.
Industry payments across TX — which companies pay providers there.
